Skip to content

Psyco Quality of Life and Procreation BRCA1/2

Women With BRCA1/2 Mutation: Guilt Feelings and Impact on Procreation Decision

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05857670
Acronym
QoL
Enrollment
200
Registered
2023-05-12
Start date
2022-05-31
Completion date
2024-12-31
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Genetic Predisposition

Brief summary

Women with breast and/or ovarian cancer or with a family history carried these pathologies can makeo genetic counseling in order to investigate whether they are carriers of the BRCA1/2 genetic mutation. This mutation exposes them to develop breast cancer from 50 to 80% and from 27 to 65% of developing ovarian cancer. BRCA1/2 mutations are inherited as an autosomal dominant manner and therefore there is a 50% probability of transmitting the mutation to the progeny. For this reason, women who have BRCA 1/2 mutation may be less likely to want children than those who test negative. The decision to have children could worry both for the probability to transfer the genetic mutation or because the parenthood could be compromised by the illness and/or by premature death. In previous studies, the psychological condition of patients with BRCA 1/2 mutations, with or without children, was only partially investigated. For this reason the main goal of the study is to deeply investigate the specific psychological condition, with particular attention to the guilt feelings on the possibility to transfer the genetic mutation to the progeny. In this wai it could be useful to development a therapeutic strategies aimed at the best adaptation of the patients to the new health condition.

Interventions

BEHAVIORALGenetic predisposition to breast cancer

Guilt feelings about procreating

Sponsors

Regina Elena Cancer Institute
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Women with BRCA1/2 mutation affected or not by breast neoplasm * Women with BRCA1/2 mutation affected or not by breast neoplasm and with at least a son/daughter * Women with at list middle school diploma * Women available to do interviews

Exclusion criteria

* Women with other oncological pathology * Women with cognitive deficient and/or inability to comply to the requirements of the study

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of feeling guilting24 monts* ISGR-15s * Il PFQ-2 * PHQ-9

Countries

Italy

Contacts

Primary ContactAnita Caruso
anita.caruso@ifo.it+39 06 52665332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026